FDA is working with federal partners, international regulators and medical product companies to quickly address any potential impacts of the omicron variant.
Read more: Coronavirus (COVID-19) Update: FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters